Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy.

Boogerd LS, van der Valk MJ, Boonstra MC, Prevoo HA, Hilling DE, van de Velde CJ, Sier CF, Fariña Sarasqueta A, Vahrmeijer AL.

Onco Targets Ther. 2018 Mar 23;11:1655-1664. doi: 10.2147/OTT.S145473. eCollection 2018.

2.

Can serum dynamics of carcinoembryonic antigen level during neoadjuvant chemoradiotherapy in rectal cancer predict tumor response and recurrence? A multi-institutional retrospective study.

Chung MJ, Nam TK, Jeong JU, Kim SH, Kim K, Jang HS, Jeong BK, Lee JH.

Int J Colorectal Dis. 2016 Sep;31(9):1595-601. doi: 10.1007/s00384-016-2629-z. Epub 2016 Jul 28.

PMID:
27464635
3.

In Search for Optimal Targets for Intraoperative Fluorescence Imaging of Peritoneal Metastasis From Colorectal Cancer.

Hoogstins CE, Weixler B, Boogerd LS, Hoppener DJ, Prevoo HA, Sier CF, Burger JW, Verhoef C, Bhairosingh S, Farina Sarasqueta A, Burggraaf J, Vahrmeijer AL.

Biomark Cancer. 2017 Aug 28;9:1179299X17728254. doi: 10.1177/1179299X17728254. eCollection 2017.

4.

Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.

Park YA, Sohn SK, Seong J, Baik SH, Lee KY, Kim NK, Cho CW.

J Surg Oncol. 2006 Feb 1;93(2):145-50.

PMID:
16425302
5.

Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.

Park JW, Lim SB, Kim DY, Jung KH, Hong YS, Chang HJ, Choi HS, Jeong SY.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):810-7. doi: 10.1016/j.ijrobp.2008.08.057. Epub 2008 Dec 26.

PMID:
19101093
6.

Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei.

Nummela P, Leinonen H, Järvinen P, Thiel A, Järvinen H, Lepistö A, Ristimäki A.

Hum Pathol. 2016 Aug;54:47-54. doi: 10.1016/j.humpath.2016.02.022. Epub 2016 Mar 30.

PMID:
27038681
8.

Clinical significance of serial serum carcinoembryonic antigen values for treating rectal cancer with preoperative chemoradiotherapy.

Ryu YJ, Kim CH, Kim HJ, Kang H, Lim SW, Huh JW, Ju JK, Kim YJ, Kim HR.

J Korean Soc Coloproctol. 2012 Aug;28(4):205-12. Epub 2012 Aug 31.

9.

Cytokeratin 19, carcinoembryonic antigen, and epithelial cell adhesion molecule detect lung cancer lymph node metastasis in endobronchial ultrasound-guided transbronchial aspiration samples.

Bugalho A, Martins C, Dias SS, Nunes G, Silva Z, Correia M, Marques Gomes MJ, Videira PA.

Clin Lung Cancer. 2013 Nov;14(6):704-12. doi: 10.1016/j.cllc.2013.06.004. Epub 2013 Jul 22.

PMID:
23886796
10.

[Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].

Sprenger T, Rothe H, Beissbarth T, Conradi LC, Kauffels A, Homayounfar K, Behnes CL, Rödel C, Liersch T, Ghadimi M.

Chirurg. 2016 Jul;87(7):593-601. doi: 10.1007/s00104-016-0170-9. German.

PMID:
27106241
11.

Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancer.

Huang CS, Lin JK, Wang LW, Liang WY, Lin CC, Lan YT, Wang HS, Yang SH, Jiang JK, Chen WS, Lin TC, Chang SC.

Am J Surg. 2014 Jul;208(1):99-105. doi: 10.1016/j.amjsurg.2013.08.054. Epub 2014 Jan 16.

PMID:
24524862
12.

Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.

Yang KL, Yang SH, Liang WY, Kuo YJ, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Chang SC, Chu LS, Wang LW.

Radiat Oncol. 2013 Mar 1;8:43. doi: 10.1186/1748-717X-8-43.

13.

Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.

Hall MA, Pinkston KL, Wilganowski N, Robinson H, Ghosh P, Azhdarinia A, Vazquez-Arreguin K, Kolonin AM, Harvey BR, Sevick-Muraca EM.

J Nucl Med. 2012 Sep;53(9):1427-37. doi: 10.2967/jnumed.112.106302. Epub 2012 Aug 7.

14.

Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation.

Han YD, Kim WR, Park SW, Cho MS, Hur H, Min BS, Baik SH, Lee KY, Kim NK.

Medicine (Baltimore). 2015 Nov;94(45):e1971. doi: 10.1097/MD.0000000000001971.

15.

Immunohistochemical expression of epithelial cell adhesion molecule (EpCAM) in mucoepidermoid carcinoma compared to normal salivary gland tissues.

Kamal NM, Salem HM, Dahmoush HM.

Arch Oral Biol. 2017 Jul;79:87-94. doi: 10.1016/j.archoralbio.2017.03.014. Epub 2017 Mar 21.

PMID:
28347886
16.

Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy.

Yeo SG, Kim DY, Chang HJ, Park JW, Oh JH, Kim BC, Baek JY, Kim SY, Kim TH.

Tumori. 2013 Jan-Feb;99(1):93-9. doi: 10.1700/1248.13795.

PMID:
23549007
17.

Differences in carcinoembryonic antigen levels between colon and rectal cancer.

Ding Y, Xuan W, Chen C, Chen Z, Yang Z, Zuo Y, Ren S.

Mol Clin Oncol. 2014 Jul;2(4):618-622. Epub 2014 Apr 30.

19.

Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.

Kim CW, Yu CS, Yang SS, Kim KH, Yoon YS, Yoon SN, Lim SB, Kim JC.

Ann Surg Oncol. 2011 Nov;18(12):3271-7. doi: 10.1245/s10434-011-1740-1. Epub 2011 May 3.

PMID:
21537868
20.

The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.

Liu GC, Zhang X, Xie E, An X, Cai PQ, Zhu Y, Tang JH, Kong LH, Lin JZ, Pan ZZ, Ding PR.

Medicine (Baltimore). 2015 Nov;94(47):e2074. doi: 10.1097/MD.0000000000002074.

Supplemental Content

Support Center